In ESCC tumor tissues, EGFR is frequently overexpressed or often amplified, with activation of the PI3K/AKT signaling pathway due to mutations in the PI3KCA gene and loss of PTEN expression [36,37,38]. The gene discussed is EGFR; the disease is esophageal squamous cell carcinoma.